Research Summary
PD-1 (Programmed Cell Death Protein 1) and PD-L1 (Programmed Cell Death Ligand 1) inhibitors are a class of immunotherapy drugs used in cancer treatment. PD-1 is a protein found on the surface of certain immune cells, while PD-L1 is a protein found on some cancer cells. The interaction between PD-1 and PD-L1 can suppress the immune system's ability to recognize and attack cancer cells, allowing cancer to evade the body's natural defenses. PD-1 and PD-L1 inhibitors are designed to block this interaction, thereby ? 1/4 ?releasing the brakes? 1/4 ? on the immune system and allowing it to recognize and attack cancer cells more effectively. These inhibitors have shown remarkable success in treating various types of cancer, improving patient outcomes, and often leading to long-lasting responses. They are part of the broader field of immune checkpoint inhibitors, which are transforming the landscape of cancer therapy by harnessing the body's immune system to combat cancer.
According to DIResearch's in-depth investigation and research, the global PD-1 and PD-L1 Inhibitors market size will reach US$ XX Million in 2024, and is expected to reach US$ XX Million in 2030, with a CAGR of XX% (2025-2030). Among them, the China market has changed rapidly in the past few years. The market size in 2024 will be US$ XX Million, accounting for approximately XX% of the world. It is expected to reach US$ XX Million in 2030, and the global share will reach XX%.
The major global manufacturers of PD-1 and PD-L1 Inhibitors include Merck, Bristol-Myers Squibb, Pfizer, Sanofi, Regeneron Pharmaceuticals, Roche, AstraZeneca, Hengrui Medicine, Beigene, Innovent Biologics, Junshi Biosciences, Akeso, Alphamab Oncology etc. The global players competition landscape in this report is divided into three tiers. The first tiers is the global leading enterprise, which occupies a major market share, is in a leading position in the industry, has strong competitiveness and influence, and has a large revenue scale; the second tiers has a certain share and popularity in the market, actively follows the industry leaders in product, service or technological innovation, and has a medium revenue scale; the third tiers has a smaller share in the market, has a lower brand awareness, mainly focuses on the local market, and has a relatively small revenue scale.
This report studies the market size, price trends and future development prospects of PD-1 and PD-L1 Inhibitors. Focus on analysing the market share, product portfolio, prices, sales volume, revenue and gross profit margin of global major manufacturers, as well as the market status and trends of different product types and applications in the global PD-1 and PD-L1 Inhibitors market. The report data covers historical data from 2019 to 2023, based year in 2024 and forecast data from 2025 to 2030.
The regions and countries in the report include North America, Europe, China, APAC (excl. China), Latin America and Middle East and Africa, covering the PD-1 and PD-L1 Inhibitors market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of PD-1 and PD-L1 Inhibitors industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Manufacturers of PD-1 and PD-L1 Inhibitors Include:
Merck
Bristol-Myers Squibb
Pfizer
Sanofi
Regeneron Pharmaceuticals
Roche
AstraZeneca
Hengrui Medicine
Beigene
Innovent Biologics
Junshi Biosciences
Akeso
Alphamab Oncology
PD-1 and PD-L1 Inhibitors Product Segment Include:
PD-1
PD-L1
PD-1 and PD-L1 Inhibitors Product Application Include:
Metastatic Melanoma
Non-small Cell Lung Cancer (NSCLC)
Renal Cell Carcinoma (RCC)
Others
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trends
Chapter 2: Global PD-1 and PD-L1 Inhibitors Industry PESTEL Analysis
Chapter 3: Global PD-1 and PD-L1 Inhibitors Industry Porter's Five Forces Analysis
Chapter 4: Global PD-1 and PD-L1 Inhibitors Major Regional Market Size (Revenue, Sales, Price) and Forecast Analysis
Chapter 5: Global PD-1 and PD-L1 Inhibitors Market Size and Forecast by Type and Application Analysis
Chapter 6: North America PD-1 and PD-L1 Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 7: Europe PD-1 and PD-L1 Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 8: China PD-1 and PD-L1 Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 9: APAC (Excl. China) PD-1 and PD-L1 Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 10: Latin America PD-1 and PD-L1 Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 11: Middle East and Africa PD-1 and PD-L1 Inhibitors Competitive Analysis (Market Size, Key Players and Market Share, Product Type and Application Segment Analysis, Countries Analysis)
Chapter 12: Global PD-1 and PD-L1 Inhibitors Competitive Analysis of Key Manufacturers (Sales, Revenue, Market Share, Price, Regional Distribution and Industry Concentration)
Chapter 13: Key Company Profiles (Product Portfolio, Sales, Revenue, Price and Gross Margin)
Chapter 14: Industrial Chain Analysis, Include Raw Material Suppliers, Distributors and Customers
Chapter 15: Research Findings and Conclusion
Chapter 16: Methodology and Data Sources
Table of Contents 1 PD-1 and PD-L1 Inhibitors Market Overview 1.1 Product Definition and Statistical Scope 1.2 PD-1 and PD-L1 Inhibitors Product by Type 1.2.1 Global PD-1 and PD-L1 Inhibitors Market Size by Type, 2023 VS 2024 VS 2030 1.2.2 PD-1 1.2.3 PD-L1 1.3 PD-1 and PD-L1 Inhibitors Product by Application 1.3.1 Global PD-1 and PD-L1 Inhibitors Market Size by Application, 2023 VS 2024 VS 2030 1.3.2 Metastatic Melanoma 1.3.3 Non-small Cell Lung Cancer (NSCLC) 1.3.4 Renal Cell Carcinoma (RCC) 1.3.5 Others 1.4 Global PD-1 and PD-L1 Inhibitors Market Revenue and Sales Analysis 1.4.1 Global PD-1 and PD-L1 Inhibitors Market Size Analysis (2019-2030) 1.4.2 Global PD-1 and PD-L1 Inhibitors Market Sales Analysis (2019-2030) 1.4.3 Global PD-1 and PD-L1 Inhibitors Market Sales Price Trend Analysis (2019-2030) 1.5 PD-1 and PD-L1 Inhibitors Market Development Status and Trends 1.5.1 PD-1 and PD-L1 Inhibitors Industry Development Status Analysis 1.5.2 PD-1 and PD-L1 Inhibitors Industry Development Trends Analysis 2 PD-1 and PD-L1 Inhibitors Market PESTEL Analysis 2.1 Political Factors Analysis 2.2 Economic Factors Analysis 2.3 Social Factors Analysis 2.4 Technological Factors Analysis 2.5 Environmental Factors Analysis 2.6 Legal Factors Analysis 3 PD-1 and PD-L1 Inhibitors Market Porter's Five Forces Analysis 3.1 Competitive Rivalry 3.2 Threat of New Entrants 3.3 Bargaining Power of Suppliers 3.4 Bargaining Power of Buyers 3.5 Threat of Substitutes 4 Global PD-1 and PD-L1 Inhibitors Market Analysis by Regions 4.1 PD-1 and PD-L1 Inhibitors Overall Market: 2023 VS 2024 VS 2030 4.2 Global PD-1 and PD-L1 Inhibitors Revenue and Forecast Analysis (2019-2030) 4.2.1 Global PD-1 and PD-L1 Inhibitors Revenue and Market Share by Region (2019-2024) 4.2.2 Global PD-1 and PD-L1 Inhibitors Revenue Forecast by Region (2025-2030) 4.3 Global PD-1 and PD-L1 Inhibitors Sales and Forecast Analysis (2019-2030) 4.3.1 Global PD-1 and PD-L1 Inhibitors Sales and Market Share by Region (2019-2024) 4.3.2 Global PD-1 and PD-L1 Inhibitors Sales Forecast by Region (2025-2030) 4.4 Global PD-1 and PD-L1 Inhibitors Sales Price Trend Analysis (2019-2030) 5 Global PD-1 and PD-L1 Inhibitors Market Size by Type and Application 5.1 Global PD-1 and PD-L1 Inhibitors Market Size by Type 5.1.1 Global PD-1 and PD-L1 Inhibitors Revenue and Forecast Analysis by Type (2019-2030) 5.1.2 Global PD-1 and PD-L1 Inhibitors Sales and Forecast Analysis by Type (2019-2030) 5.2 Global PD-1 and PD-L1 Inhibitors Market Size by Application 5.2.1 Global PD-1 and PD-L1 Inhibitors Revenue and Forecast Analysis by Application (2019-2030) 5.2.2 Global PD-1 and PD-L1 Inhibitors Sales and Forecast Analysis by Application (2019-2030) 6 North America 6.1 North America PD-1 and PD-L1 Inhibitors Market Size and Growth Rate Analysis (2019-2030) 6.2 North America Key Manufacturers Analysis 6.3 North America PD-1 and PD-L1 Inhibitors Market Size by Type 6.3.1 North America PD-1 and PD-L1 Inhibitors Sales by Type (2019-2030) 6.3.2 North America PD-1 and PD-L1 Inhibitors Revenue by Type (2019-2030) 6.4 North America PD-1 and PD-L1 Inhibitors Market Size by Application 6.4.1 North America PD-1 and PD-L1 Inhibitors Sales by Application (2019-2030) 6.4.2 North America PD-1 and PD-L1 Inhibitors Revenue by Application (2019-2030) 6.5 North America PD-1 and PD-L1 Inhibitors Market Size by Country 6.5.1 US 6.5.2 Canada 7 Europe 7.1 Europe PD-1 and PD-L1 Inhibitors Market Size and Growth Rate Analysis (2019-2030) 7.2 Europe Key Manufacturers Analysis 7.3 Europe PD-1 and PD-L1 Inhibitors Market Size by Type 7.3.1 Europe PD-1 and PD-L1 Inhibitors Sales by Type (2019-2030) 7.3.2 Europe PD-1 and PD-L1 Inhibitors Revenue by Type (2019-2030) 7.4 Europe PD-1 and PD-L1 Inhibitors Market Size by Application 7.4.1 Europe PD-1 and PD-L1 Inhibitors Sales by Application (2019-2030) 7.4.2 ? Europe PD-1 and PD-L1 Inhibitors Revenue by Application (2019-2030) 7.5 Europe PD-1 and PD-L1 Inhibitors Market Size by Country 7.5.1 Germany 7.5.2 France 7.5.3 United Kingdom 7.5.4 Italy 7.5.5 Spain 7.5.6 Benelux 8 China 8.1 China PD-1 and PD-L1 Inhibitors Market Size and Growth Rate Analysis (2019-2030) 8.2 China Key Manufacturers Analysis 8.3 China PD-1 and PD-L1 Inhibitors Market Size by Type 8.3.1 China PD-1 and PD-L1 Inhibitors Sales by Type (2019-2030) 8.3.2 China PD-1 and PD-L1 Inhibitors Revenue by Type (2019-2030) 8.4 China PD-1 and PD-L1 Inhibitors Market Size by Application 8.4.1 China PD-1 and PD-L1 Inhibitors Sales by Application (2019-2030) 8.4.2 China PD-1 and PD-L1 Inhibitors Revenue by Application (2019-2030) 9 APAC (excl. China) 9.1 APAC (excl. China) PD-1 and PD-L1 Inhibitors Market Size and Growth Rate Analysis (2019-2030) 9.2 APAC (excl. China) Key Manufacturers Analysis 9.3 APAC (excl. China) PD-1 and PD-L1 Inhibitors Market Size by Type 9.3.1 APAC (excl. China) PD-1 and PD-L1 Inhibitors Sales by Type (2019-2030) 9.3.2 APAC (excl. China) PD-1 and PD-L1 Inhibitors Revenue by Type (2019-2030) 9.4 APAC (excl. China) PD-1 and PD-L1 Inhibitors Market Size by Application 9.4.1 APAC (excl. China) PD-1 and PD-L1 Inhibitors Sales by Application (2019-2030) 9.4.2 APAC (excl. China) PD-1 and PD-L1 Inhibitors Revenue by Application (2019-2030) 9.5 APAC (excl. China) PD-1 and PD-L1 Inhibitors Market Size by Country 9.5.1 Japan 9.5.2 South Korea 9.5.3 India 9.5.4 Australia 9.5.5 Indonesia 9.5.6 Vietnam 9.5.7 Malaysia 9.5.8 Thailand 10 Latin America 10.1 Latin America PD-1 and PD-L1 Inhibitors Market Size and Growth Rate Analysis (2019-2030) 10.2 Latin America Key Manufacturers Analysis 10.3 Latin America PD-1 and PD-L1 Inhibitors Market Size by Type 10.3.1 Latin America PD-1 and PD-L1 Inhibitors Sales by Type (2019-2030) 10.3.2 Latin America PD-1 and PD-L1 Inhibitors Revenue by Type (2019-2030) 10.4 Latin America PD-1 and PD-L1 Inhibitors Market Size by Application 10.4.1 Latin America PD-1 and PD-L1 Inhibitors Sales by Application (2019-2030) 10.4.2 Latin America PD-1 and PD-L1 Inhibitors Revenue by Application (2019-2030) 10.5 Latin America PD-1 and PD-L1 Inhibitors Market Size by Country 10.5.1 Mexico 10.5.2 Brazil 11 Middle East & Africa 11.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Market Size and Growth Rate Analysis (2019-2030) 11.2 Middle East & Africa Key Manufacturers Analysis 11.3 Middle East & Africa PD-1 and PD-L1 Inhibitors Market Size by Type 11.3.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Type (2019-2030) 11.3.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Type (2019-2030) 11.4 Middle East & Africa PD-1 and PD-L1 Inhibitors Market Size by Application 11.4.1 Middle East & Africa PD-1 and PD-L1 Inhibitors Sales by Application (2019-2030) 11.4.2 Middle East & Africa PD-1 and PD-L1 Inhibitors Revenue by Application (2019-2030) 11.5 Middle East & Africa PD-1 and PD-L1 Inhibitors Market Size by Country 11.5.1 Saudi Arabia 11.5.2 South Africa 12 Competition by Manufacturers 12.1 Global PD-1 and PD-L1 Inhibitors Market Sales, Revenue and Price by Key Manufacturers (2020-2024) 12.1.1 Global PD-1 and PD-L1 Inhibitors Market Sales by Key Manufacturers (2020-2024) 12.1.2 Global PD-1 and PD-L1 Inhibitors Market Revenue by Key Manufacturers (2020-2024) 12.1.3 Global PD-1 and PD-L1 Inhibitors Average Sales Price by Manufacturers (2020-2024) 12.2 PD-1 and PD-L1 Inhibitors Competitive Landscape Analysis and Market Dynamic 12.2.1 PD-1 and PD-L1 Inhibitors Competitive Landscape Analysis 12.2.2 Global Key Manufacturers Headquarter Location and Key Area Sales 12.2.3 Market Dynamic 13 Key Companies Analysis 13.1 Merck 13.1.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.1.2 Merck PD-1 and PD-L1 Inhibitors Product Portfolio 13.1.3 Merck PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.2 Bristol-Myers Squibb 13.2.1 Bristol-Myers Squibb Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.2.2 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Product Portfolio 13.2.3 Bristol-Myers Squibb PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.3 Pfizer 13.3.1 Pfizer Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.3.2 Pfizer PD-1 and PD-L1 Inhibitors Product Portfolio 13.3.3 Pfizer PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.4 Sanofi 13.4.1 Sanofi Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.4.2 Sanofi PD-1 and PD-L1 Inhibitors Product Portfolio 13.4.3 Sanofi PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.5 Regeneron Pharmaceuticals 13.5.1 Regeneron Pharmaceuticals Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.5.2 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Product Portfolio 13.5.3 Regeneron Pharmaceuticals PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.6 Roche 13.6.1 Roche Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.6.2 Roche PD-1 and PD-L1 Inhibitors Product Portfolio 13.6.3 Roche PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.7 AstraZeneca 13.7.1 AstraZeneca Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.7.2 AstraZeneca PD-1 and PD-L1 Inhibitors Product Portfolio 13.7.3 AstraZeneca PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.8 Hengrui Medicine 13.8.1 Hengrui Medicine Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.8.2 Hengrui Medicine PD-1 and PD-L1 Inhibitors Product Portfolio 13.8.3 Hengrui Medicine PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.9 Beigene 13.9.1 Beigene Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.9.2 Beigene PD-1 and PD-L1 Inhibitors Product Portfolio 13.9.3 Beigene PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.10 Innovent Biologics 13.10.1 Innovent Biologics Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.10.2 Innovent Biologics PD-1 and PD-L1 Inhibitors Product Portfolio 13.10.3 Innovent Biologics PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.11 Junshi Biosciences 13.11.1 Junshi Biosciences Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.11.2 Junshi Biosciences PD-1 and PD-L1 Inhibitors Product Portfolio 13.11.3 Junshi Biosciences PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.12 Akeso 13.12.1 Akeso Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.12.2 Akeso PD-1 and PD-L1 Inhibitors Product Portfolio 13.12.3 Akeso PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 13.13 Alphamab Oncology 13.13.1 Alphamab Oncology Basic Company Profile (Employees, Areas Service, Competitors and Contact Information) 13.13.2 Alphamab Oncology PD-1 and PD-L1 Inhibitors Product Portfolio 13.13.3 Alphamab Oncology PD-1 and PD-L1 Inhibitors Market Data Analysis (Revenue, Sales, Price, Gross Margin and Market Share) (2020-2024) 14 Industry Chain Analysis 14.1 PD-1 and PD-L1 Inhibitors Industry Chain Analysis 14.2 PD-1 and PD-L1 Inhibitors Industry Upstream Supply Analysis 14.2.1 Upstream Key Raw Material Supply Analysis 14.2.2 Raw Material Suppliers and Contact Information 14.3 PD-1 and PD-L1 Inhibitors Typical Downstream Customers 14.4 PD-1 and PD-L1 Inhibitors Sales Channel Analysis 15 Research Findings and Conclusion 16 Methodology and Data Source 16.1 Methodology/Research Approach 16.2 Research Scope 16.3 Benchmarks and Assumptions 16.4 Date Source 16.4.1 Primary Sources 16.4.2 Secondary Sources 16.5 Data Cross Validation 16.6 Disclaimer
Publisher: DIResearch
Related Reports
- Global Epilepsy Therapeutics Market (2024 Edition): Analysis By Generation (First Generation, Second Generation, Third Generation), By Route of Administration, By Type, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Online Pharmacy Market (2024 Edition): Analysis By Drug Type (Over the Counter (OTC) Drugs, Prescription Drugs, Others), By Platform, By Product Type, By Region: Market Insights and Forecast (2020-2030)
- Global Diagnostic X-rays Market (2024 Edition): Analysis By Type (General Radiography, Angiography, Surgical Fluoroscopy, Mobile X ray, Other Types), By End Users, By Region, By Country: Market Insights and Forecast (2020-2030)
- Global Diagnostic Labs Market (2024 Edition): Analysis By Testing Services (Physiological Function Testing, General and Clinical Testing, Esoteric Testing, Specialized Testing, and Others), By Lab Type, By Application: Market Insights and Forecast (2020-2030)
- Lateral Flow Assays Market By Product Type (Lateral Flow Readers {Digital/Mobile Readers and Benchtop Readers} and Kits and Reagents), By Application (Clinical Testing {Pregnancy Testing, Influenza Testing, Tuberculosis, D-Dimer Testing, and Other Clinical Testing}, Drug Abuse Testing, Veterinary Diagnostics, Food Safety & Environmental Testing, and Other Applications), By Technique (Sandwich Assay, Competitive Assay, and Multiplex Assay), By End-User (Home Care, Hospitals and Clinics, and Other End Users), Global Market Size, Segmental analysis, Regional Overview, Company share analysis, Leading Company Profiles And Market Forecast, 2025 - 2035
Why Market Study Report?
- Best Price for Reports
- Large Report Database
- Easily Customize Reports
- 24/7 Email & Phone Support